Compare D Wave Quantum Inc (QBTS) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
D Wave Quantum Inc vs Smith & Nephew plc — how do they compare? D Wave Quantum Inc trades at $14.57 (market cap $5.54B), while Smith & Nephew plc trades at $27.24 (market cap $11.10B). The key difference: Smith & Nephew plc is far larger — about 2× D Wave Quantum Inc's market cap, and Smith & Nephew plc pays a 2.95% dividend while D Wave Quantum Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold D Wave Quantum Inc for 32 Days and Smith & Nephew plc for 121 Days on average.
| QBTS | SNN | |
|---|---|---|
Market Cap | $5.54B | $11.10B |
Volume | 16,671,452 | 1,051,703 |
Sector | Technology | Health |
52-Week High | $44.78 | $37.17 |
52-Week Low | $12.98 | $26.42 |
Typical Hold Time | 32 Days | 121 Days |
Enterprise Value | $5.04B | $14.13B |
Dividend Yield | — | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
D-Wave Quantum (QBTS) trades at $14.57, down 4.27% today, amid ongoing legal investigations and negative earnings trends. The stock shows bearish technical signals with oversold RSI readings, while fundamentals reveal severe losses with a -2,001.59% net income margin despite 64.19% gross margins. Recent quarterly earnings have been mixed, missing expectations in two of the last three reported quarters.
Despite unanimous analyst buy ratings and a $34.38 price target suggesting 136% upside, significant execution risks persist. The company faces cash burn challenges with negative operating cash flow and relies heavily on financing activities. Legal investigations and competitive pressures in the quantum computing sector create substantial uncertainty for investors.
SNN trades at $26.96, up 0.26% on the day, but near its 52-week low amid a bearish technical signal. Recent earnings have mostly beaten expectations, with Q2 2026 EPS of $0.946 exceeding the $0.939 estimate. Revenue grew to $6.16B in 2025, and net income margin improved to 10.08%. The company continues to launch new medical products, such as the EVOS PELVIC System, to drive growth.
The outlook is mixed; strong fundamentals and product innovation support long-term value, but near-term price pressure and analyst caution pose risks. Investors should weigh robust profitability against competitive threats and recent management changes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About D Wave Quantum Inc
D-Wave Quantum Inc. is a global leader in the development and delivery of quantum computing systems, software, and services. The company specializes in annealing quantum computers designed to solve complex optimization problems across industries such as logistics, materials science, and financial modeling. D-Wave offers its technology through the cloud, allowing customers to build and run real-world quantum applications today, making it a key player in the commercialization of quantum computing.
Read more on QBTS →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
